Ennolys is expanding its contract manufacturing services to accelerate and mitigate the risks associated with the industrialization of sustainable innovations

With more than 30 years of expertise in industrial fermentation, Ennolys is strengthening its position as a key partner in supporting its clients’ biotechnology projects, from bioprocess development through to commercial production.

This new offer covers fermentation, purification (DSP), and drying processes, with industrial equipment and a dedicated team to optimize performance, ensure a smooth scale-up, and accelerate time to market.

Ennolys’ teams produce a wide range of microorganisms and metabolites derived from fermentation—such as enzymes, probiotics, postbiotics, proteins, peptides, and other molecules of interest—for the food, cosmetics, nutraceuticals, agricultural, and animal nutrition markets…

With this new offer, Ennolys now provides comprehensive, customized support, drawing on proven fermentation processes and cutting-edge technologies. With a dedicated team of experts, Ennolys is involved in every stage of the project—from laboratory R&D to scale-up to industrial production in large-capacity fermenters—optimizing yields, quality, and reproducibility. This flexible and collaborative approach enables manufacturers to reduce development costs, accelerate time-to-market, and secure their supply chain.

“Expanding our CDMO service offer provides a concrete solution to the challenges facing the biotechnology industry. Thanks to our long-standing expertise in fermentation and our capabilities in DSP and drying, we support our customers from the laboratory stage through to industrial production, enabling them to accelerate and secure their development. Together, we turn their needs into sustainable industrial success.” – says Jean de Lataillade, CEO of Ennolys by Lesaffre.

“This expansion of Ennolys’ offer illustrates Lesaffre’s commitment to putting its fermentation expertise at the service of innovators. It will help foster the development of sustainable solutions that address the major challenges of tomorrow.”– Brice-Audren Riché, Lesaffre CEO.

For Lesaffre, this initiative is part of a broader effort to forge new partnerships within the biotech ecosystem. Ennolys’ CDMO offer is a concrete example of how Lesaffre’s expertise in fermentation can help address real needs through an approach that is at once industrial, scientific, and environmentally responsible.